Seyed Shahabeddin Mortazavi-Jahromi

4PUBLICATIONS
8CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsGene and molecular therapyPharmaceutical delivery technologiesGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 01, 2020
The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients.

Seyed Shahabeddin Mortazavi-Jahromi, Arman Ahmadzadeh, Zahra Rezaieyazdi

|Nov 02, 2019
Immunopharmacological effect of β-d-mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR-155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patients.

Seyed Shahabeddin Mortazavi-Jahromi, Mona Aslani, Saiedeh Omidian

|Jan 04, 2019
International multicenter randomized, placebo-controlled phase III clinical trial of β-D-mannuronic acid in rheumatoid arthritis patients.

Zahra Rezaieyazdi, Abid Farooqi, Hossein Soleymani-Salehabadi

|Jun 09, 2018
Anti-diabetic effect of β-D-mannuronic acid (M2000) as a novel NSAID with immunosuppressive property on insulin production, blood glucose, and inflammatory markers in the experimental diabetes model.

Seyed Shahabeddin Mortazavi-Jahromi, Shahab Alizadeh, Mohammad Hassan Javanbakht

Pageof 1

Frequent Collaborators

4 joint publications

Abbas Mirshafiey

3 joint publications

Zahra Rezaieyazdi

3 joint publications

Arman Ahmadzadeh

1 joint publications

Mohammad Hassan Javanbakht